February 01, 2015 2:10 AM ET


Company Overview of Okairos AG

Executive Profile

Riccardo Cortese Ph.D., M.D.

Co-Founder, Chief Executive Officer, Managing Director and Director, Okairos AG
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Prof. Riccardo Cortese, Ph.D., M.D., Co-Founded Okairos AG and serves as its Chief Executive Officer. Prof. Cortese was the founder and first Director of the Gene Expression Program of the European Molecular Biology Laboratory (EMBL), Heidelberg and founder and Scientific Director of IRBM, which subsequently became a subsidiary of Merck, Inc. He has coordinated the efforts leading to the development of several novel antiviral drugs and vaccines, which are now already ...

Corporate Headquarters

Aeschenvorstadt 71
Basel, Basel-Stadt 4051


Phone: 41 61 270 35 35
Fax: 41 61 270 35 00

Board Members Memberships

Co-Founder, Chief Executive Officer, Managing Director and Director
Independent Director and Member of Remuneration Committee


University of California
Universita' degli Studi di Napoli Federico II

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Okairos AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.